Loading
Latest filing published 17 Jul 2026 for Catalyst Pharmaceuticals, INC., €102k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Molly Harper in Catalyst Pharmaceuticals, Inc. In total, 14 filings cover trades dated from 15 February 2023 to 15 July 2026.
The open-market record consists of 2 sales worth €132k, with no purchase. The rest of the record consists of 11 option exercises.
On 17 July 2026 came the latest disclosure, a transaction for €102k in Catalyst Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations